Jane Tiller, MBChB, FRCPsych, M.B.A., M.Phil., is Global Head of Development for Neuroscience at Johnson & Johnson, where she leads all Neuroscience global clinical development initiatives.
Prior to joining Johnson and Johnson, Jane was Chief Medical Officer of Neumora Therapeutics. She previously served as Chief Medical Officer of BlackThorn Therapeutics, a private biotechnology company. Before joining BlackThorn, Jane was Head of Medical European Markets, Australia and Canada at Bristol-Myers Squibb (BMS). While at BMS, she also served as Vice President of Global Medical for neuroscience, virology and immunoscience, and as Vice President, Full Development Gamma Secretase for the BMS Alzheimer’s disease program. Previously, she held positions of increasing responsibility at Cephalon, including Vice President, Clinical Research, CNS/Pain, where she was responsible for all clinical development activities.
Before joining industry, Jane was Clinical Director at the Maudsley Hospital, London; a Consultant Psychiatrist and honorary Senior Lecturer. She received her medical degree from the Glasgow University Medical School, a Master of Business Administration from Drexel University and a Master of Philosophy in Organizational Dynamics from the University of Pennsylvania.